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1. Introduction
In spite of its small size (31,500 hectares), the Maltese Archipelago hosts a large number of
medicinal and aromatic plants that have been utilised medicinally for several centuries. The
Maltese Archipelago lies in the middle of the Mediterranean Sea, 35°50’ north of the Equator
and 14°35’ east of Greenwich. The climate is characterized by hot dry summers, mild wet winters
(an average rainfall of 500 mm and temperatures ranging between 13°C in winter and 35°C in
summer) and a high relative humidity all the year round. Most of the wild plants thrive in very
shallow soil pockets that, in some cases, contribute to the production of phytochemicals as a
means of protection against other plants or other organisms. In general, Maltese soils contain a
high amount of calcium carbonate (>53%), which is the parent rock material, a high pH (>8) and
a high clay content with a good physical structure but lacking organic matter (<4.5 %).
The  Maltese  flora  comprises  around  1284  vascular  plants  66%  originating  from  the
Mediterranean region while the other 34% originating from the cold European and warm
subtropical regions [1]. Out of these, there are about 458 medicinal taxa with approximately 300
originating from the Mediterranean region. The main plant families of medicinal importance
are Asteraceae (15%), Lamiaceae (7%), Fabaceae (6%), Umbelliferae (4%) and Rosaceae (4%)
amongst others. The biodiversity in medicinal flora is high probably due to several reasons that
include:
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• favourable Mediterranean climate
• availability of fertile calcareous soils
• considerable area of uncultivated land (wastelands)
• former conquerors of the Maltese Islands
• Maltese interest in herbal medicine
The number of medicinal species is on the decline to the extent that some have already become
extinct. This is not mainly attributed to overuse problems but due to various human activities.
There were isolated cases where a medicinal plant was under treat due to over-harvesting.
One typical example was the seaside squill (Drimia maritima) which was over-harvested due
to export.
2. Medicinal flora of the Maltese islands
The pharmacological assessment of the Maltese medicinal flora, contributed to a portion of the
research conducted on these species. Intensive research has been conducted in other fields,
particularly in the ethnobotanical, agronomic, in vitro propagation and phytochemical fields.
Phytochemistry plays a very important role in medicinal plant research (figure 1). The quality
and safety of these plants depends mainly on their phytochemical constitution. These metab‐
olites determine the categorization of plants; whether a medicine, food supplement or
cosmetic. The quality and quantity of these metabolites depends mainly on the growing
conditions. This instigated researchers to study different aspects of medicinal plants with
phytochemistry as the common aspect.
Figure 1. The importance of phytochemistry in medicinal plant research
Medicinal plants have been classified either on their phytochemical constitution or else on their
pharmacological activities. These plant contain a myriad of metabolite classes and single
Phytochemicals - Isolation, Characterisation and Role in Human Health4
metabolites. In most cases, more has to be discovered as the information is either unavailable
or else still uninvestigated yet. Locally, medicinal plants have been classified on their phar‐
macological activity. Some would include the following effects: cardiotonic (e.g. squill,
oleander), anticancer (e.g. squirting cucumber, borage), immunomodulatory (e.g. squirting
cucumber, olive tree), antiflammatory and skin disorders (e.g. marigold, aloe, erica), antihy‐
pertensive (e.g. hawthorn), antimicrobial and antifungal (poison ivy, sage, garden basil, sticky
fleabane, couch grass, garlic, fig tree, caper plant, pellitory of the Wall), antidiabetic (karela),
insect repellents and insecticides (pennyroyal, tree tobacco), antihelmintic (pumpkin),
spasmodic and antispasmodic (vervain, henbane), sedative (blue passion flower, orange-
flower water, chamomile), kidney stone problems (micromeria), volatile oil (lavander, garden
rue, lemon balm, rosemary, laurel, spearmint) and fixed oils (olive tree, castor oil plant). Some
of these plants are listed in table 1.
Local ethnobotanical research has contributed towards the discovery of new leads. In such
studies, the traditional claims are challenged using scientific methods. Possible conservation
strategies were also considered, particularly for endangered species. However, there are
limitations since there are no national incentives to conserve these plant species unless
cultivated or sold as pot plants. However, there are few plants that are legally bound. A typical
example is the carob tree. The grower cannot uproot a carob tree to pursue cultivation needs.
Latin name Family Common name Maltese name
Drimia maritima (L.) Stearn Asparagaceae Seaside squill Basla tal-għansar
Ecballium elaterium (L.) A.Rich. Cucurbitaceae Squirting cucumber Faqqus il-ħmir
Mentha pulegium L. Lamiaceae Pennyroyal Plejju
Salvia officinalis L. Lamiaceae Garden sage Salvja
Verbena officinalis L. Verbenaceae Vervain Buqexrem
Hedera helix L. Araliaceae Common ivy Liedna
Crataegus monogyna Jacq. Rosaceae Common hawthorn Anżalor salvaġġ
Calendula officinalis L. Asteraceae Pot marigold Suffejra
Melissa officinalis L. Lamiaceae Lemon balm Burieħa
Olea europea L. Oleaceae Olive tree Żebbuġa
Urtica dubia Forsk. Urticaceae Stinging nettle Ħurrieqa
Capparis spinosa L. Capparaceae Caper plant Kappara
Ephedra fragilis Desf. Ephedraceae Mormon tea Efedra
Nicotiana glauca RC Graham Solanaceae Tree tobacco Tabakk tas-swar
Table 1. The Maltese medicinal plants in this study.
2.1. Drimia maritima (L.) Stearn
Drimia maritima or Urginea maritima is one of the local medicinal plants which was harvested
and exported. It is a member of the Asparagaceae family, with cardiac glycosides that reside
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in the bulb of this plant. It is renowned for its emetic, diuretic, cardiotonic [2], expectorant,
rodenticide [3] and anticancer activities. The seaside squill has been extensively studied for its
propagation potential. Locally, cultivation studies have been associated with the cardiac
glycosidic content while micropropagation has been linked to biomass production.
The main constituents of the seaside squill are the cardiac glycosides and phenolic compounds
[4]. It also contains mucilage and calcium oxalate crystals. The squill cardiac glycosides are
bufadienolides. In principle, these are similar to triterpenoids having a sugar group and a
lactone ring at C17. Scillaren A accounts for about 70% of the total glycosidal content of squill.
It contains one unit of rhamnose and one unit of glucose. When scillaren A is hydrolyzed by
enzymes, it breaks down to proscillaridin A and D-glucose (Figure 2).
Figure 2. The structure of cardiac glycosides of Drimia maritima (L.) Stearn.: (A) Scillaren A and (B) Proscillaridin A
These glycosides act by binding to the Na+/K+ ATPase pumps. This occurs due to the presence
of the lactone group [5, 6]. These bufadienolides are therefore important cardiotonic, blood
pressure stimulating and antitumour agents. The main glycosides with digoxin-like effects are
scillaren A and proscillaridin A [7].
Several cultivation parameters were studied for Drimia maritima in relation to dry matter yield
and the total glycosidal content [8]. These include methods of propagation, planting at different
depths, effects of nitrogen (N), phosphorus (P) and potassium (K) fertilizers, cultivation in
different soil types, age of harvesting and seasonal timing of harvesting. Propagation by bulb
division only takes 10 weeks to produce a seedling as opposed to seed propagation that
requires 56 weeks. The type of soil does not contribute to the variation of glycosides in the
squill bulb. In fact, Maltese squill grown on four soil types, namely terra soil, xerorendzina
soil, carbonate raw and sandy soil exhibited average glycosidal contents of 0.575 % (w/w).
Fertiliser studies revealed that the use of different ratios of N, P and K affect the rate of growth
but no change in glycosidal content (average of 0.59 % w/w). For the best annual production
of dry weight and glycosidal content, it is advisable to harvest squill in the third year after
transplanting (table 2) immediately after flowering. The highest glycosidal content is obtained
from the roots (Figure 3)
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Year of harvest Treatment Mean glycosidal content(%)
First Control 0.25Fertiliser-treated 0.26
Second Control 0.66Fertiliser-treated 0.68
Third Control 0.57Fertiliser-treated 0.58
Fourth Control 0.58Fertiliser-treated 0.58
Fifth Control 0.38Fertiliser-treated 0.40
Sixth
Control 0.31
Fertiliser-treated 0.34
Table 2. The mean percentage glycosidal content in the squill bulb with year of harvest [8].
 
Figure 3. The mean percentage glycosidal content in different parts of the squill bulb [8].
Micropropagation of squill was carried out by direct and indirect organogenesis. Regeneration
was successfully achieved using bulb explants by direct organogenesis. Although the process
of regeneration was slow, callus cultures maintained in high auxin concentrations (4 mg/l 2,4-
D + 2 mg/l NAA) induced root formation, when the plant growth regulators (PGRs) were
removed [9].
2.2. Ecballium elaterium (L.) A.Rich.
Ecballium elaterium (squirting cucumber), a member of the Cucurbitaceae family, is a Mediter‐
ranean medicinal plant in a monotypic genus. In the past, the squirting cucumber was used as
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a purgative, emetic, for the treatment of jaundice and oedema. It was also used for the treatment
of otitis, hydrophobia and malarial fever. Locally, it was prepared in various dosage forms
such as powders, solutions, semisolid blocks and dried cubes for exportation. It also used to
be prepared in the form of lozenges with gum Arabic. The fresh fruit juice was renowned for
several pharmacological effects mainly as antibilirubinaemic, antihepatotoxic and lacrimation
stimulant. The dried juice, also known as the elaterium, was effective as a laxative, anti-
inflammatory, antitumour and as an aflatoxin suppressor [10, 11]. Most of these pharmaco‐
logical effects have been proven through various scientific investigations.
The main constituents of this plant are the cucurbitacins (Cu), the major ones being CuE and
CuB (Figure 4), particularly present in the fruit juice. Other cucurbitacins include cucurbitacins
D, G, H, I, R, L, hexanorcucurbitacin I, 16-deoxy-∆16-hexanorcucurbitacin O, anhydro-22-
deoxo-3-epi-isocucurbitacin D, and their glycosides [12-14]. The squirting cucumber also
contains sterols, fatty acids, elaterases, tannins [15], complex phenolic compounds and
flavonoids [16], amino acids and their derivatives as well as the Ecballium elaterium protease
inhibitors (EEPIs). These EEPIs are obtained from seed extracts and are effective against at
least four different serine proteinases [17]. In fact, these are termed as trypsin inhibitors I, II,
and III, also known as the trypsin isoinhibitors (EETIso), chymotrypsin inhibitor (8 kDa),
subtilisin inhibitor (9 kDa), and elastase inhibitor, and Astacus protease inhibitor [18].
Figure 4. The structures of (A) cucurbitacin E and (B) Cucurbitacin B found in Ecballium elaterium (L.) A.Rich.
Although this plant is abundant in wastelands throughout the Maltese Archipelago, micro‐
propagation was attempted for two main reasons. These were as a means to study the
responses of explants from the squirting cucumber to different plant growth regulators, and
to determine the potential propagation of high-yielding mother plants. In this attempt, seeds
were germinated in Murashige-Skoog (MS) medium. Different concentrations and types of
PGRs, mainly auxins and cytokinins, were added. Subculturing with the different PGRs was
performed every 4 weeks and explants were maintained at about 25 ± 1 °C and 3250 ± 250 lx.
Once developed, the plantlets were transferred to Jiffy® pots until rooting and then repotted
(compost:peat:perlite, 2:2:1) until flowering [19]. The main four responses of explants were
bud multiplication, shoot elongation, callus production and rooting, as illustrated in Figure 5.
A regeneration protocol was devised as follows. Briefly, the seeds were germinated on MS
medium (8 - 9 weeks). Bud multiplication of node explants was performed on naphthalene‐
acetic acid/6-benzylaminopurine (NAA/BAP) medium (for 2 - 3 subcultures every 4 weeks).
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shoot elongation was obtained on Gibberellic Acid (GA3) medium (4 weeks), followed by an
auxin shock on Indole-3-acetic acid (IAA) medium (1 week) then, treated with rooting hormone
powder and finally transfer to Jiffy® pots (3 - 4 weeks). The plants were then repotting and
acclimatised for 4 - 5 weeks [19]. The whole process takes between 24 and 35 weeks.
The Ecballium elaterium explants produced a high amount of callus and this led to further
studies to determine the production of cucurbitacins in these undifferentiated cells. Callus
masses were treated with different PGRs at different concentrations. The best PGR combina‐
tion for biomass accumulation was 2,4-Dichlorophenoxyacetic acid/kinetin (2,4D/Ki) while for
metabolite production, the NAA/BAP combinations showed optimum yields [20]. A growth-
linked accumulation of metabolites was observed (figure 6).
The production of cucurbitacins from cultivated sources, is significantly higher in fruit
compared to stems and leaves (figure 7). A drop in ambient temperature results in lower
production of cucurbitacins [21].
Pharmacological testing has been extensively carried out on this plant. Extracts exhibited a
marked effect on prostate cancer cells (IC50= 9.35 nM) and moderate effects on melanoma and
breast cancer cells (IC50 = 0.87 and 1.95 μM, respectively) in vitro. Negligible cytotoxic effects
Figure 5. The effects of plant growth regulators on Ecballium elaterium explants in tissue culture [20].
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were observed on normal fibroblasts (IC50 = 93.8 μM) [22]. It was demonstrated that CuE
provoked apoptosis in cancer cell lines. This was exhibited by the condensation of chromatin
and also DNA fragmentation using gel electrophoresis. CuE was also effective as an immune
modulator. Human peripheral T-lymphocytes were freshly isolated and challenged with
phytohaemagglutinin (PHA) and Ecballium elaterium extracts [23]. Cucurbitacins in the juice
Figure 6. Growth-linked accumulation of metabolites in Ecballium elaterium cultures.
Figure 7. The total cucurbitacin content in elaterium produced from Ecballium elaterium fruit, stems and leaves with
time and temperature [21].
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extract of Ecballium elaterium, also exhibited potential anti-inflammatory, analgesic and
antipyretic activities in rodents [10, 24].
2.3. Mentha pulegium L.
Mentha pulegium L. is a perennial plant, belonging to the Lamiaceae family. During Roman
times, the plant was used for several ailments particularly for headaches, flatulence and even
as an abortifacient. The name ‘pulegium’ derived from the Latin word ‘pulex’ for flea, indicates
that in Roman times the plant was used as a flea repellent [25]. Locally, it was well-reputed as
a treatment for common cold, as a carminative, emmenagogue but also as an insect repellent
[26]. Mentha pulegium used to be hung in wardrobes to ward off fleas and placed on windowsills
to repel mosquitoes especially during the summer months. The most important extract from
this plant is the essential oil, known as the pennyroyal oil.
In a study by [27], pennyroyal oil contained 38.0% piperitone, 33.0% piperitenone, 4.7% α-
terpineol and 2.3% pulegone as the major components (Figure 8). The authors concluded that
Iranian pennyroyal oil is rich in piperitone/piperitenone. In another study, the pulegone
content of Iranian pennyroyal oil ranged between 1.3 – 52.0%, when extracted by supercritical
fluid extraction, while hydrodistillation yielded around 37.8% of pulegone. Piperitenone
consituted only 6.8% to the extracted essential oil [28]. Similarly, in another study [29], the
content of pulegone in Greek pennyroyal oil was in the range of 42.9% and 90.7% attributed
to two populations. In other wild populations, the pulegone content did not exceed 35.6%.
Such populations were rich in either menthone/isomenthone or in piperitone/piperitenone. In
Tunisian pennyroyal oil, 41.8 % of the oil was pulegone [30] while Portuguese pennyroyal oil
contained 23.2 % of pulegone [31]. The pennyroyal oil was extracted from wild Maltese
populations using hydrodistillation with a yield of 0.73 % [32]. The pulegone content in the oil
was 85.8 %, followed by other constituents; (-) limonene (0.984 %), myrcene (0.109 %) and β-
pinene (0.191 %). This was determined by GC-FID.
Figure 8. The most abundant monoterpenoids of Mentha pulegium L. essential oil: (A) pulegone, (B) piperitone, (C) pi‐
peritenone, (D) α-terpineol and (E) menthofuran.
Apart from its abortifacient activity, pennyroyal oil is also hepatotoxic and causes pulmonary
necrosis. Hepatotoxicity is mainly attributed to the conversion of pulegone into its epoxide or
menthofuran derivatives [33-35].
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Insect repellent activity of pennyroyal was determined by using two setups (Figure 9) with
citronella oil and distilled water used as positive and negative controls, respectively [32]. Setup
1 consisted of a trough with a diameter of 30 cm and a height of 12 cm. Four zones were
designated within the trough (Figure 9A). The mosquitoes were introduced inside the
container, and the oil sample was then injected by a syringe. Sixteen mosquitoes were observed
every two minutes for a period of 20 minutes and their position within the trough was
recorded. After the second minute, 75 % of the mosquitoes were found in the compartment
furthest from the injection site. A gradient was achieved at this time interval and the mosqui‐
toes moved away from the source. After the tenth minute, this compartmental difference was
no longer observed, most probably due to the fact that the oil must have saturated the trough
and hence there was no trend in mosquito distribution. Setup 2 consisted of a glass tube with
an internal diameter of 2.5 cm and a length of 150 cm. Seven zones were designated within the
tube (Figure 9B). Twenty mosquitoes were observed every two minutes for half an hour and
their position recorded, following injection of the pennyroyal oil. As with setup 1, there was
a statistical difference between zone 1 and zone 7 of the tube, but this difference became
negligible with time. Similar results were observed with citronella. In spite of this similarity,
GC-FID determination of the citronella oil revealed the presence of geraniol (60.0 %), citronellal
(15.0 %) and camphene (> 15.0 %), but no significant pulegone content. With water a more
random distribution of mosquitoes was observed [32].
Figure 9. The experimental setups used to determine the insect repellent properties of pennyroyal oil [32].
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Pennyroyal oil exhibited repellent and insecticidal effects. After 90 minutes exposure, none of
the mosquitoes were airborne and those that were in contact with the oil were dead. The insect
repellent activity was attributed to the high pulegone content [36].
2.4. Salvia officinalis L.
Salvia officinalis, more commonly known as garden sage, is a member of the Lamiaceae family.
Sage has been renowned for its healing properties since the Ancient Greeks. The Romans
inherited the medicinal knowledge on sage and used it to enhance diuresis, menstruation and
to stop bleeding of wounds. It was also used to treat pain associated with colds and rheumatism
[37]. Scientifically, sage has several medicinal properties, such as, antioxidant [38, 39], anti‐
bacterial [40], anti-inflammatory [41] and antiviral effects [42] and is also used to control
Alzheimer’s disease [43]
Sage contains several metabolites primarily monoterpenoids and sesquiterpenoids, diterpe‐
noids [43], triterpenoids, such as ursolic and oleanolic acid [41, 44], and also flavonoids and
phenolic glycosides [45]. The essential oil of Portuguese sage according to [46] contains α-
thujone (17.4 %), α-humulene (13.3 %), 1,8-cineole (12.7 %), E-caryophyllene (8.5%) and borneol
(8.3%) as major constituents. In another study [47], the sage essential oil contained mainly α-
thujone (29.1 %), camphor (26.3 %), 1,8-cineole (9.3 %), α-humulene (4.4 %) and terpinen-4-ol
(4.0%). Similar results were obtained in a local study [48], where the Maltese sage oil was found
to contain mainly α-thujone (29.28 %), camphor (26.61 %) and 1,8-cineole (15.53 %) as the major
constituents (Figure 10).
Figure 10. The common constituents of Salvia officinalis L. essential oil: (A) thujone, (B) camphor, (C) 1,8-cineole and
(D) carnosolic acid.
Another significantly important metabolite in sage is carnosolic acid, a bitter abietane diterpe‐
noid derivative with a carboxylic acid structure. This compound possesses antimicrobial,
antioxidant, antiviral and anticancer activities [49]. Carnosolic acid was extracted using Soxhlet
extraction and petroleum ether as extractant. The extract was dried and dissolved in pyridine/
acetic anhydride. The neutral fraction was then chromatographed using silica gel as support [48].
Cultivation studies revealed that sage is best cultivated under shade conditions with irrigation.
Propagation is best performed by cuttings every three weeks during spring after the plants
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have ceased to flower. The recommended planting distance is 30 cm in a row with a cultivation
density of 10 plants per m2. Plants should be irrigated immediately after planting of cuttings
and twice weekly in summer. The monthly harvesting of leaves produced a variable content
of essential oil on fresh weight basis with the peak reached during the month of August (2.24
% v/v) and the least during December (0.52 % v/v) (Figure 11).
Figure 11. The yield of Maltese sage essential oil throughout the year [48].
2.5. Verbena officinalis L.
Verbena officinalis, a member of the Verbenaceae family, is also known as vervain. This plant is
indigenous to Europe, North Africa and Asia but has been introduced to North America and
Australia. Some of the common traditional uses of vervain, worldwide, were in the treatment
of respiratory problems such as cough, wheezing and shortness of breath [37], as a purgative,
in the treatment of haemorrhoids, eye problems [50], wounds, fever and stomach upsets [51].
In Malta, vervain was used in the treatment of many ailments particularly, carbuncles, boils,
wounds, eczema, high blood pressure, diarrhoea, dysentery, cough and arthritis [52].
The main constituents of Verbena officinalis are iridoid glycosides, namely verbenalin [53],
hastatoside [54] and aucubin [55]. It yields an essential oil, with citral, geraniol, limonene and
verbenone as main constituents [56]. Other constituents include the flavone derivative
artemetin, phenylpropane glycosides verbascoside and eukovoside and the triterpenes ursolic
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acid, β-sitosterol and lupeol [57]. Some of these constituents are highlighted in figure 12. The
volume of oil obtained from Maltese sources was negligible [58].
Figure 12. Typical constituents of Verbena officinalis L.: (A) verbenalin, (B) artemetin and (C) verbascoside
A hydromethanolic extract of the dried aerial parts of Maltese vervain was obtained by Soxhlet
extraction [58]. The constitution of verbenalin was determined by HPLC using Supelcosil LC-18
column, acetonitrile/water-phosphoric acid (pH 2) gradient mobile phase with a flow rate of
1.5 ml/min. The content of verbenalin expressed as dry weight of plant material was 2.09 % (w/
w). Previous reports [59] declared that contents of verbenalin were less than 0.1 % when extracted
with ether but the content in methanolic extracts varied between 0.12 and 0.50 % [60].
Several pharmacological activities are attributed to vervain, namely, anti-inflammatory [54,
61], neuroprotective [62], antioxidant, antifungal [63], antileukaemic [64] and hepatoprotective
[65]. Verbenalin, from Maltese vervain sources, was tested on mammalian intestinal smooth
muscle in vitro and compared to acetylcholine [58]. Final molar concentrations of acetylcholine
(40nM to 10 μM) and verbenalin (21.3 μM to 2.6 mM) were prepared. The smooth muscle was
placed in an organ bath with a 30 ml-muscle chamber in freshly prepared Tyrode’s solution
maintained at 37°C. The muscle was challenged for a period of 30 seconds with the two
substances at the stated concentrations (Figure 13). Between additions, the muscle was allowed
to achieve baseline activity. The median effective concentration for acetylcholine and verbe‐
nalin were 1.54 μM and 0.32mM, respectively, with acetylcholine being approximately 200
times more potent than verbenalin. In spite of its mild effects, the presence of verbenalin in
vervain is not recommended in pregnancy [66].
2.6. Hedera helix L.
Hedera helix L. or common ivy, a member of the Araliaceae family, is indigenous to Europe but
its presence has been reported in Asia (as far as Japan), Africa and North America. Records of
the use of ivy as a medicinal plant, dates back to the times of Hippocrates. The flowers were
used to treat dysentery, earache and headache, while the leaves were usedas an emmenagogue
[67). Others claimed it to be effective in the treatment of sunburn, ulcers, tuberculosis,
bronchitis, whooping-cough, constipation, wounds and various skin diseases [68-70].
The main constituents of Hedera helix are the saponins, more commonly known as hederasa‐
ponins. This is a group of structurally related triterpenoid glycosides with an oleanane
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backbone (Figure 14). These are divided into mono- and bidesmosides. Monodesmosides
include α-hederin and hederagenin 3-O-β-glucoside, while bidesmosides include hederasa‐
ponins С, A, B, D, E, F, G, H and I [71, 72].
Figure 14. The main pentacyclic triterpenoids of Hedera helix L.
Another important group is that represented by phenolics (flavonoids, anthocyanins, cou‐
marins and phenolic acids) [71, 73]. The essential oil from ivy stems and leaves contains
germacrene D, β-caryophyllene, sabinene, β-pinene, limonene, and α-pinene [74]. Hederasa‐
ponins, from ivy grown in Malta, were extracted with 70 % ethanol by Soxhlet extraction [75].
Spring, summer, autumn and winter leaves yielded 12.75 %, 11.82 %, 10.74 % and 10.97 % (w/
w) of dried extract. The hederosaponin content was determined by HPLC using Supelcosil LC-
18 column, acetonitrile/water-phosphoric acid (0.01 N) gradient mobile phase with a flow rate
of 1 ml/min. Hederasaponin C and α-hederin were used as standards. The 70 % ethanolic
extract contained 46.7 % hederasaponin C and 6.1 % α-hederin totaling 52.8 %. Purification of
the ethanolic extract through an alumina column with methanol as solvent resulted in 62.2 %
hederasaponin C and 9.2 % α-hederin. This goes in accordance with other authors [76, 77] who
confirmed that hederasaponin C is the main saponin in common ivy.
Figure 13. The spasmodic response of the smooth intestinal muscle with (a) acetylcholine and (b) verbenalin [58].
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Hedera helix was investigated for its pharmacological potential, by many scientists. Typical
reported activities include anti-inflammatory [78, 79], antiviral [80], antifungal [81], antibac‐
terial, mucolytic, antispasmodic agent and in vitro bronchodilatory [82, 83].
The ivy leaf extracts, obtained from Maltese sources, and the standards were tested for their
antimicrobial activity [75]. The tested organisms were Staphylococcus aureus, Escherichia coli,
Enterobacter aerogenes, Klebsiella sp., Serrata sp. and Candida albicans. Pure α-hederin was
inactive against all organisms presumably due to its poor solubility in water as was reported
by [84]. On the other hand, pure hederasaponin C was active against all the tested organisms.
It was more active than both ivy extracts against Staphylococcus aureus, Enterobacter aerogenes,
Klebsiella sp. and Serrata sp. It was just as effective as the purified ivy extract against Escherichia
coli and Candida albicans. The only difference between hederasaponin C and α-hederin is that
the former has an extra sugar group. Being a bidesmoside, hederasaponin C is more water
soluble. There are no other structural differences that may have contributed to a better
antimicrobial activity. In conclusion, the purified ivy extract (62.2 % hederasaponin C) and
pure hedersaponin C were more active against Staph. aureus and least active against Candida
albicans (table 3).
Microorganism
Minimum Inhibitory Concentrations (mg/l)
hederasaponin C α-hederin Ethanolic extract Purified ethanolicextract
Staph. aureus 0.312 - 1.25 – 2.50 0.625 – 1.25
Escherichia coli 5 - 10 5 - 10
Enterobacter aerogenes 2.5 - 5 – 10 5 – 10
Klebsiella sp. 1.25 - 5 – 10 2.5 – 5
Serrata sp 2.5 - 5 – 10 -
Candida albicans 10 - - 10
Table 3. Minimum Inhibitory Concentrations (mg/l) for Hedera extracts [75].
2.7. Crataegus monogyna Jacq.
Crataegus monogyna (may, quick or common hawthorn) belongs to the Rosaceae family.
Records show that it has been used since the Ancient Roman times. Dioscorides and later
Paracelsus reported the effects of the shrub in heart conditions [85]. Mediterranean folk
medicine utilized the shrub as an astringent, febrifuge, sedative, in the treatment of diarrhoea,
whitlow’s, heart disease, high blood pressure and to improve circulation [86].
Hawthorn contains several constituents, most of which are either pharmacologically active or
have a nutritional value. Triterpenoids, flavonoids, coumarins and amines are the main groups
of compounds that possess a significant activity in the treatment of cardiovascular diseases [87].
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The two triterpenoids, abundantly found in hawthorns, are ursolic and oleanolic acids (figure
15). These account for 90 % of the total pentacyclic triterpenoids present in the shrub [88]. The
triterpenoids oleanolic, ursolic and crataegolic acids were extracted as a crude mixture with
96 % alcohol [89, 90], as an acid-ether extract [91] and as a tincture of Crataegus monogyna [92].
Figure 15. Structure of oleanolic acid and derivatives. For oleanolic acid, R1 and R2 are hydrogen atoms. For the triter‐
penoid glycosides, R1 and R2 represent different sugar groups.
Crataegus species are renowned for their flavonoid content [93]. Flavonoids include vitexin,
hyperoside [94], rutin, quercetin, luteolin-7-glucoside [95] and apigenin [96]. The most
abundant in flowers was the hyperoside [94]. Other flavonoids included catechin, luteolin,
epicatechin, quercetrin, quercetrin-3-rhamnogalactoside and luteolin-3’,7-diglucoside [87, 97].
Hawthorn contains a large variety of cardiotonic amines in different plants parts especially
the leaves and flowers. These include di- and trimethylamine, ethanolamine, ethylamine [87],
isoamyl and isobutylamines [92]. Choline and acetylcholine are also present. It contains other
minor constituents [98].
Hawthorn extracts have been tested for several pharmacological activities such as antimicro‐
bial, antioxidant [99, 100], peroxysmal tachycardia [101], prevention of cardiac necrosis
[102-104], hyperglycaemia [105], atherosclerosis [106] and hypertension [107].
The hydroethanolic extract of Crataegus monogyna was studied for its angiotensin-convert‐
ing  enzyme  (ACE)  inhibitory  activity  [108].  The  direct  interaction  of  extracts  and  pure
compounds with ACE was performed using a microtiter  plate method modified for  the
ACE detection kit (Sigma, MO) at 430 nm (Figure 16). The crude extract contained triterpenic
acids, flavonoids and coumarins. The ACE inhibitory activity of the crude extract and pure
oleanolic acid (a triterpenoid) were compared to captropril, the latter used as a control drug.
The hydroethanolic extract and oleanolic acid showed higher IC50 values (335.00 μg/ml and
3.61 μM, respectively) in comparison to captopril (46.9 nM). However, these results suggest
that the anti-ACE activity of the hydroethanolic extract from hawthorn is due to oleanol‐
ic acid and other triterpenic acids present. This was the first study to suggest that triterpen‐
ic acids contribute to the antihypertensive activity of hawthorn. In previous studies,  the
ACE inhibitory activity of C. monogyna  extracts was always attributed to flavonoids and
proanthocyanidins.
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Figure 16. The interaction of angiotensin converting enzyme and compounds (such as captopril and oleanolic acid)
with the chromophore N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine (FAPGG).
2.8. Calendula officinalis L.
Calendula officinalis, more commonly known as the pot marigold, belongs to the Asteraceae
family. The use of pot marigold for therapeutic purposes has been recognised since the time
of St. Hildeguard (1098-1197), who described in her work Causae et Curae and Physica the
curative properties of ringula [109]. Calendula officinalis was being used internally during the
twelfth century for digestive disturbances and also as an antidote against man and animal
intoxication. It was also used externally for the treatment of impetigous eczema. Hundred
years later (1193-1280), Albert the Great utilized the Calendula which he called Sponsa Solis,
against animal bites and also to alleviate hepatic pain and pain of the spleen. This plant can
also be seen in the herbals of the Renaissance. Leonard Fuchs stated that if the plant was to be
boiled and held in the mouth for some time it relieved dental pain. Later during the sixteenth
Century, Mattioli (1500-1577) attributed the therapeutic properties of the pot marigold in the
constriction of the heart and palpitations as a consequence of menstrual fluid retention.
According to this author, the water of the marigold has sudatory properties. He was also the
first physician to recommend the herb for its therapeutic use against cancer and accordingly
called it Herba Cancri. Mattioli's recommendations of Calendula officinalis as a remedy against
cancer were fully approved by Osiander and Hufeland [109]. The pharmacist, J. W. Weinmann
(1683 - 1741), in his work "Phytantoza iconographica" recommended the aqueous marigold
extract for the alleviation of red and inflamed eyes and also used the plant in the treatment of
goitre.
Pharmacologically-active classes of compounds, in the marigold, include the terpenoids
including the carotenoids, flavonoids, coumarins and polysaccharides [110-112]. The sapono‐
sides are particularly abundant in the plant. There are also numerous triterpenoid alcohols
which are derived from tarassene, lupene, oleanene and ursene. These are present as free or
esterified as monols, diols and triols. The content of monoesters of the triterpenoid diols is
between 2 and 45 %, of which 1.85 % is made up of faradiol esters. The most common triter‐
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penoid is oleanolic acid (Figure 15). The colour of the flowers is determined by the amount of
carotenoids which can vary from 1.5 to 3 %. The orange flowers are made up mainly of
carotenes particularly lycopene whereas the yellow flowers contain mainly xanthophylls [113].
The heterosides of quercetin and isorhamnetin (flavonoids) are present in the dry Calendula
drug [114]. Their content varies between 0.25 and 0.88 %. The Calendula drug contains 14.75 %
of polysaccharides (PS), which are soluble in water. The three main ones are PS I (molecular
weight of 15,000), PS II (molecular weight of 25,000) and PS III (molecular weight of 35,000).
These are made up of galactose, rhamnose and arabinose subunits. Other constituents include
the essential oil, triterpene alcohols, phenolic acids, tannins, sterols, tocopherols, N-paraffins,
pyrethrins, sesquiterpenes and coumarins. Monoterpenes and sesquiterpenes make up the
essential oil. However, the latter does not contain sesquiterpene lactones. Moreover, 50 - 60 %
of the oil present in the seeds is made up of calendulic acid, an unsaturated fatty acid having
an unusual chemical structure.
Flowerheads of Calendula officinalis were extracted with methanol and following concentration,
the extract was hydrolysed with 0.5 M hydrochloric acid. The mixture was centrifuged and
the residue was dissolved in chloroform. This was then dried and subjected to column
chromatography (silica gel; mobile phase - petroleum ether:dichloroethylene:acetic acid
50:50:0.7). The collected fractions were analysed by melting point determination, Infrared and
Ultraviolet spectroscopy. The content of oleanolic acid extracted from the dried flowerheads
was 0.13% (w/w) [115].
The marigold has been investigated for its anti-microbial, anti-inflammatory [116, 117], anti-
tumour [110] activities, effects on the cardiovascular and nervous systems [118, 119] as well as
oestrogenic [120], hypolipidaemic [121], anti-ulcer [122] and spermicidal properties [123].
The antimicrobial activity was conducted for oleanolic acid against a number of organisms
[115]. Due to the insoluble nature of oleanolic acid in water, it was incorporated in the nutrient
agar for bacterial strains and in Sabouraud’s dextrose agar for fungi. In fact, [124] stated that
the anti-bacterial agent was soluble in alcohol but not in water. According to the results
obtained after 24 hours in the study performed, oleanolic acid was active against Gram-positive
organisms (Strep. faecalis, Strep. viridans and Staph. aureus) except Staph. albus. However, for
Staph. albus, there was slight inhibition which resulted in hazy growth. On the other hand, it
was inactive against Gram-negative strains. Although for Morganella species and Pseudomonas
aeruginosa, there was some degree of inhibition, the plate which contained the ethanol instead
of oleanolic acid showed the same degree of inhibition. Hence, the anti-bacterial activity in
these two cases might be attributable to the presence of ethanol. Oleanolic acid did not show
any activity against Candida albicans.
The topical in vivo effects of oleanolic acid (2.5 %) on inflamed bites induced by mosquitoes
(Culex pipiens) was studied [115]. The positive and negative controls included indomethacin
(2.5 %), hydrocortisone (1 %) and petroleum jelly. The topical anti-inflammatory activity of
oleanolic acid, over a 24-hour period, was comparable to that of hydrocortisone, after being
applied at 8 hourly periods. However, when compared to indomethacin, oleanolic acid was
found to be less effective (P<0.01). In accordance with the study conducted by [125], oleanolic
acid was found to have similar effects to those of hydrocortisone. However, other studies relate
oleanolic acid to non-steroidal anti-inflammatory agents, like indomethacin [126].
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2.9. Melissa officinalis L.
Melissa officinalis L. is a member of the Lamiaceae family. It is also known as lemon balm or
simply as balm. The Latin name ‘‘Melissa’’ (balm) refers to the Greek word ‘melitos’, that is
honey. It is believed that the plant attracts honey bees. The plant is found mainly in the
Mediterranean region and eastwards to Asia and Siberia. Balm is renowned for its effects on
the nervous system and is used to treat nervous agitation, insomnia, hysteria, melancholia,
migraine, headache, toothache, earache and nerve pains. It is also useful for gastrointestinal
problems such as gastric complaints and lower abdominal pain [127, 128].
Lemon balm contains a volatile oil [129], flavonoids (cynaroside, rhamnocitrin, isoquercitrin,
cosmosin), phenolic acids (carnosic acid and rosmarinic acid), and triterpene acids (particu‐
larly ursolic and oleanolic acid) [130]. The study by [131] focused mainly on the cultivation
parameters that affect the quantity and quality of the lemon balm oil. The oil yield was 0.1 %
(v/w) with cis-citral and trans-citral as the major constituents (figure 17).
Figure 17. The main constituents of Melissa officinalis essential oil: (A) citronellal, (B) geranial (trans-citral), (C) neral
(cis-citral), (D) trans-caryophyllene
Seeds were procured from four sources: Maltese (Argotti Gardens), Swiss (Basel Botanic
Gardens), German A (Botanischer Garten der Martin-Luther-Universität) and German B
(Botanischer Garten der RWTH). The planting distance was of 20 cm in a row with a distance
of 50-60 cm between rows. The cultivation density was of 10 – 12 plants per m2. The plants
were irrigated immediately after transplanting and then once every fortnight in winter but
twice weekly in summer. Plots were divided into two: half treated with fertiliser (NPK Mg
(12+12+17+2) + Trace elements) while the other half left untreated, as a control. The leaves were
harvested in May and subjected to steam distillation extraction and GC-MS analysis. Table 4
illustrates the results obtained in this study.
In most cases, the use of fertilizer improved content of the two main terpenoids, geranial and
neral. This goes in accordance with [132], stating that nitrogen fertilisers increased the yield of
these constituents. In some cases citronellal also showed significant increases with fertilizer
application. In another study, the oil yield was found to vary between 0.16 and 0.25% [133].
With farmyard manure, the content of neral (28.23%) and geranial (39.86%) was higher than
with other treatments. Oil yield was also significantly affected by planting spacing and nutrient
amendments.
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2.10. Olea europea L.
Olea europea L. is a typical Mediterranean plant within the Oleaceae family with culinary and
medicinal virtues. The typical extract from this plant is the fixed oil obtained from the fruit. In
the ancient world, by 2000 BC the olive tree was already in cultivation. Olive and olive oil was
used and traded by the Egyptians, Phoenicians, Greeks and Romans. Today, a large number
of olive varieties are recognised internationally as table olives and olives for oil production.
Extracts from the olive tree were used in the treatment of hypertension, hyperglycaemia,
hyperacidity [134], constipation, for treatment of wounds, sunburn and muscle aches [135,
52] amongst others.
The bioactive phenolic compounds present in the olive fruit include phenolic acids, phenolic
alcohols, flavonoids and secoiridoids. The main phenolic acids are cinnamic, syringic, p-
coumaric, vanillic, caffeic, 3,4-dihydroxyphenylacetic and protocatechuic acid [136]. Phenolic
alcohols include 3,4-dihydroxyphenylethanol (hydroxytyrosol) and p-hydroxyphenylethanol
(tyrosol) [137-139]. Flavonoids include taxifolin, apigenin, luteolin and lignans represented by
pinoresinol and its metabolites [140]. However, an important class of metabolites found in the
leaves and fruit of Olea, is that of the secoiridoid glycosides. These include oleuropein (figure
18), demethyloleuropein, oleuropein aglycone and elenolic acid [141-144].
Oleuropein was extracted from Maltese olives as follows [145].The leaves were defatted with
petroleum ether and then extracted with 50% ethanol for 6-8 hours. The dried extract was then
treated with water and sodium chloride was added until saturation was achieved. Chloroform
was added and the aqueous extract was collected. Ethylacetate was added to the aqueous
extract and following partitioning, the ethylacetate extract was collected. The extract was then
subjected to dryness in order to obtain a yellow crystalline substance. Oleuropein in the olive
leaf ethanolic extract amounts to 20.6 %, as mentioned by [146], with a content varying from
20 to 25% (w/w) total dry weight.
Olea europea was tested for its antimicrobial [147, 148], antiviral [149], antioxidant [146, 150],
antihypertensive, antiatherosclerotic [151, 152] and antidiabetic [153] activities amongst
Sample Citronellal Nerol Geranial Neral Caryophyllene
Maltese
w/o Fertiliser 0.00 0.00 37.11 47.39 1.02
Fertiliser 0.52 0.00 36.82 47.74 1.26
Swiss
w/o Fertiliser 0.55 0.00 36.08 48.92 2.11
Fertiliser 1.31 0.55 30.73 45.13 2.67
German A
w/o Fertiliser 1.24 0.57 30.96 45.79 2.62
Fertiliser 1.25 0.71 32.11 47.23 1.84
German B
w/o Fertiliser 1.65 0.56 31.39 47.63 2.13
Fertiliser 1.31 0.74 33.42 49.19 1.94
Table 4. The composition of essential oils obtained from lemon balm of different seed origins [131].
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others. Maltese olive leaf extract was studied for its immunomodulatory activity [145]. Human
peripheral blood lymphocytes were isolated and cultured on RPMI medium. Oleuropein (540
– 0.054 μg/ml) was tested alongside phytohaemagglutinin (m-form, Gibco BRL, UK - 1 – 0.0001
% as positive control and Olea extracts to final concentrations ranging from 540 – 0.054 μg/ml
(oleuropein content). The cells were studied for their survival, death and morphological
characteristics using WST-1 assay, LDH (Boehringer-Mannheim, Germany) and the Papani‐
colau staining procedure, respectively. Oleuropein possesses three α,β -moieties; two α, β -
unsaturated keto systems at the 3,4-dihydroxyphenyl part and one α, β -unsaturated aldehyde
system on the secoiridoid part, which are important for the non-toxic but stimulatory activity
on lymphocytes. From the results obtained, oleuropein was more effective when it formed part
of the extract (SC50, < 0.054 μg/ml) than when used in its pure form (SC50, 0.146 μg/ml).
2.11. Urtica dubia Forsk.
Urtica dubia Forsk., stinging nettle, is a member of the Urticaceae family. The Urtica species are
common weeds found growing wild throughout the temperate zones of both hemispheres
worldwide. These species are renowned for their stinging sensation when touched. Since
Ancient Greek times, stinging nettle was used as a medical treatment for septic wounds,
nosebleeds and as an emmenagogue [154]. They were later used as diuretics and laxatives, in
the treatment of asthma, pleurisy, dog bites, tinea and mouth ulcers [155]. In Malta, Urtica
dubia was used in the treatment of pneumonia, chilblains, as a metabolic stimulant, to improve
blood circulation and as a diuretic [156].
Stinging nettle contains bioactive amines such as 5-hydroxytryptamine; flavonoids such as
quercetin, kaempferol and their glycosides; coumarins such as scopoletin; organic acids such
as caffeic acid and chlorogenic acid; fatty acids such as erucic acid, α-linolenic acid and linoleic
acid; an essential oil; carotenoids such as lutein, β-carotene, neoxanthin, violaxanthin and
lycopene; agglutinins such as Urtica dioica agglutinin (Figure 19); and phytosterols such as β-
amyrin, stigmasterol, oleanolic acid and β-sitosterol [157-163]. The isolation of Urtica dubia
agglutinin (UDuA) was based on a procedure described by [164] with some modification [165].
Briefly, the fresh plant materials (rhizomes, leaves and stems) were homogenised with 0.1N
Figure 18. Structures of polyphenolic compounds from olive oil: (A) hydroxytyrosol and (B) oleuropein glucoside.
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HCl (200 g/l) and allowed for 24 h shaking. The filtrate was passed through series of extractions
with 2N NaOH and (NH4)2SO4 solutions. The final agglutinin purified extract was washed
with phosphate buffer saline (PBS) which was used as the medium for the bioassays. Phyto‐
haemagglutinin (PHA, Invitrogen) was prepared likewise in PBS. The content of UDuA in the
rhizomes, leaves and stems was 0.49 %, 0.65 % and 0.16 %, respectively.
Figure 19. The crystal structure of Urtica dioica agglutinin isolectin I [166].
The stinging nettle possesses several pharmacological activities, namely antioxidant, antimi‐
crobial, antiulcer and analgesic activities [167], anti-inflammatory effects [168] and cardiovas‐
cular effects [169]. The UDuA extracts from the Maltese Urtica dubia were tested for
haemagglutination activity on human red blood cells (RBCs) [165]. Briefly, a 1% suspension
of RBCs was prepared and 100 μl aliquots were tested with different concentrations of UDuA
and PHA. The agglutination was quantified by lysing the precipitated agglutinated cells and
read spectrophotometrically at a wavelength of 405 nm at 20, 40, 60 and 80 minutes. Over the
80-min period, the best results were obtained after 60 min, as was observed by [170] for the
snowdrop lectin. Extracts from all three plant parts exhibited superior haemagglutination
activity (AgA) to the standard PHA lectin (AgA - 3.996 ± 0.259). The highest activity was
exhibited by the stems, followed by roots and leaves (AgA - 4.824 ± 0.301, 4.693 ± 0.368 and
4.594 ± 0.417, respectively at 1% concentrations).
2.12. Capparis spinosa L.
Capparis spinosa L. is a member of the Capparaceae family, also known as the caper plant. Today
it is renowned for its culinary uses, particularly in the Mediterranean region. When stored in
brine, the intensive and slightly pungent taste of the capers is preserved. Capers were used
since prehistoric times, although it is believed that other Capparis species were actually utilised
rather than Capparis spinosa [171]. In the past, the root bark and leaves were used as aperient,
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tonic, diuretic and expectorant while the flowers were used as anthelmintic, emmenagogue,
analgesic, antimicrobial, antifertility, anti-inflammatory, hepatoprotective, antihyperglyce‐
mic, immuno-stimulant and in the treatment of anaemia, diabetes, heart problems, amongst
other uses [172]. In Malta, caper extracts were used as diuretics, in the treatment of skin rashes
and pain associated with gout [135].
According to [173], the capers contain 79% moisture, 1.6% ash, 5.8% protein, 1.6% fat and 5.4%
raw fibre. It contains several minerals such as, Ca (871 ppm), Mg (636 ppm), K (542 mg/100mL),
Na (226 ppm), Fe (13 ppm) and P (21 mg/100g). Other valuable constituents include the
flavonoids such as rutin, kaempferol and its glycosides; alkaloids (Figure 20) such as cadabi‐
cine [174], capparisine A, capparisine B, capparisine C; 2-(5-hydroxymethyl-2-formylpyrrol-1-
yl) propionic acid lactone and N-(3′-maleimidy1)-5-hydroxymethyl-2-pyrrole formaldehyde
[175]. Other constituents include aldehydes, esters, sesquiterpenes, monoterpenes and sulphur
compounds with methyl-isothiocyanate as the main constituent [176], carotenoids with lutein
as the main constituent [177], sterols such as β-sitosterol, campesterol, stigmasterol, 5-
avenasterol, cholesterol and campestanol [178], and a lectin (Capparis spinosa lectin) [179].
Figure 20. Typical Capparis spinosa L. alkaloids: (A) capparisine and (B) cadabicine.
Metabolites from the Maltese caper plant were obtained by extracting the plant material with
four different solvents [180]. The xanthoproteic test for proteins [181], Fehling’s test for
carbohydrates, Sudan IV test for fats and lipids [182], Dragendorff’s test for alkaloids [183],
triphenyltetrazolium test for terpenoids and the acidified vanillin test for flavonoids [184] were
carried out on the extracts. The petroleum ether extract (0.020 % w/w plant material) contained
fats and lipids, the aqueous/methanol extract (2.401 % w/w plant material) contained proteins
and terpenoids, the methanol extract (1.398 % w/w plant material) contained alkaloids, while
the aqueous extract (3.015 % w/w plant material) contained carbohydrates and terpenoids.
The caper plant was tested for several pharmacological activities such as antiviral [185], anti-
arthritic [186], anti-oxidant [187], hypolipidaemic [188], antihyperglycaemic [189], chondro‐
cyte protective [190], antiallergic, antihistaminic [191], antifungal [192], anti-Leishmania [193]
and antimicrobial [194]. The Brine shrimp test was conducted for the extracts derived from the
Maltese caper plants [180]. Briefly, Artemia salina eggs were hatched and challenged with
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various concentrations of the extracts ranging between 0.0001 and 1 % as 1 in 10 dilutions.
After 24 hour the number of dead larvae (nauplii) was determined. The aqueous extract
exhibited the lowest LC50 (0.014%) compared to the methanol (0.0475%) and the aqueous/
methanol (0.08%) extracts. The chloroform extract did not reach a 50% lethal effect and
therefore the LC50 could not be determined. According to [195] the methanol, aqueous and
aqueous/methanol extracts were all active as their LC50 was below the 0.1% threshold.
2.13. Ephedra fragilis Desf.
Ephedra fragilis Desf., a member of the Ephedraceae family, is also known as Mormon tea.
Ephedra has been listed amongst the most important herbs used by Ancient Chinese civilisa‐
tions. It was known as Ma Huang and was used to treat coughs, colds, headache and fever. It
was later used by the Chinese to treat asthma [196] and acute nephritis [197]. This plant contains
alkaloids [198], amino acids, proteins [199], tannins and fatty acids [200]. The volatile oil of
Ephedra fragilis contains (E)-phytol (10.1%), pentacosane (5.2%), 6,10,14-trimethyl-2-pentade‐
canone (5.3%), cis-thujopsene (3.5%), and α-terpineol (3.0%) as the major components [201].
Flavonoids, minerals, and vitamins are also present. The principle alkaloid present in this plant
is ephedrine [198] (Figure 21).
Figure 21. Ephedrine, pseudoephedrine and methylephedrine
Aerial parts of local cultivated Ephedra fragilis specimen were dried in an oven at 30ºC for 48
h, pulverized and dispersed in distilled water for 25 min. After thorough mixing for 30 min at
30ºC (twice), the filtrate was treated with sodium carbonate (15 g). An equal volume of benzene
was added and then acidifed and treated with acidifed water. After neutralisation to a pH of
7, the precipitate was oven dried. The alkaloidal content in the different plant parts was
determined; 1.8675 % (w/w) in flowers, 0.6234 % in seeds, 0.5198 % in pods and seeds, 0.1389
% in dried pods and 0.0547 % in branches [202].
Clinically, ephedra has been tested for its anti-hypertensive [203], bronchodilator [204],
decongestant [205], diuretic [206] and immune booster [207]. The immunomodulatory
response of ephedrine and the Ephedra extract were studied on human peripheral lymphocytes
[202]. Cell viability, cytotoxicity and morphological characteristics were recorded for the test
substances and phytohaemagglutinin (PHA), a mitogen known to stimulate cell division of T-
lymphocytes. Over the 96-hour treatment, ephedrine and Ephedra extracts exhibited high cell
viability (> 97% viability) and blastogenesis when compared to the untreated control. The
control cells measured 6-10 μm, while treated cells measured 20-40 μm in diameter. The
ephedrine present in Ephedra extracts exhibited a direct effect on lymphocytes in vitro.
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2.14. Nicotiana glauca RC Graham
Nicotiana glauca RC Graham belongs to the Solanaceae family and is known as tree tobacco. This
was native to South America but is now naturalized in North America, the Mediterranean,
and Africa. Since, this plant was considered as poisonous [208], it has been rarely used in
tradition. The more toxic counterpart, Nicotiana tabacum was used for several conditions
particularly to expel leeches [209], against snakebite [210] and scabies [211].
Tree  tobacco contains  pyridine alkaloids  [212],  as  for  other  Nicotiana  species.  The major
pyridine  alkaloids  are  nicotine  and  anabasine  (figure  22).  Nicotine  predominated  in
Nicotiana  tabacum  [213]  and  Nicotiana  rustica  [214]  whereas  anabasine  predominates  in
Nicotiana glauca [214, 215].
Figure 22. (A) Nicotine, (B) Nornicotine and (C) Anabasine, the main pyridine alkaloids of Nicotiana species.
The leaves of Maltese Nicotiana glauca were dried and extracted with 200ml of 0.5% sodium
hydroxide [216]. After volume reduction, chloroform was added to extract the alkaloids in this
organic phase. This phase was then treated with acidified water (0.05M hydrochloric acid) and
then neutralised with ammonia solution to a pH of 7. The presence of alkaloids was tested at
each step using the Dragendorff’s reagent [217] and the anabasine content was determined by
HPLC. A Shimadzu LC-10A HPLC (Shimadzu, Kyoto, Japan) using a C18 MicroBondapak
column, 250 x 4.6mm, 10mm was used. The mobile phase consisted of 40 % methanol con‐
taining 0.2 % phosphoric acid buffered to pH 7.25 with triethylamine [218]. The anabasine
standard was used for calibration and for the determination of anabasine in Nicotiana extracts.
In the Maltese study, the anabasine content (0.258 ± 0.0042 %) concords very closely with the
results obtained in a study in Arizona (0.233 ± 0.0061 % anabasine) [219]. In another HPLC
determination, the anabasine content of Nicotiana glauca plants in California, was 0.143 % [220].
The nicotine and anabasine have been widely used as pesticides. Nicotine is a powerful
insecticide towards aphids [221] and larvae of lepidopterous pests [222]. Anabasine and
nicotine exert their insecticidal effect by interacting with nicotinic acetylcholine receptors [222,
223]. Anabasine and Nicotiana glauca extracts were tested for their effects against Pieris rapae
larvae [216]. The paralysis of the larvae was an indicator of activity. Standard anabasine
produced an effect on Pieris rapae larvae (EC50 - 0.572 mg/larva or 0.286 %) which was higher
to that provoked by the extract (EC50 - 1.202 mg/larva or 0.601 %). It is possible that alongside
anabasine there may be other metabolites that interfered with anabasine hence reducing the
response of the caterpillars to anabasine.
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3. Conclusion and further directions
The studies on the fourteen Maltese medicinal plants, presented herein, demonstrate a wide
array of experimental work that is all associated with phytochemical research. This is a very
small fraction of the Maltese medicinal flora, but in terms of research, this represents a diversity
of research protocols that may be adopted for medicinal plant research. In some cases,
phytochemical analysis is the end-point of the research whereas in others, phytochemical
analysis leads on to further studies, including pharmacological testing.
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